Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The American Journal of Medicine|November 1, 1979
Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in manA P Niarchos, A J Roberts, J H Laragh
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Plasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive manA P Niarchos, T G Pickering, A Morganti, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Vasodilating drugs: contrasting haemodynamic effectsR C Tarazi, H P Dustan, E L Bravo, et al.
The American Journal of Medicine|October 1, 1985
Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapyA P Niarchos, L M Resnick, D L Weinstein, et al.
American Heart Journal|October 1, 1982
Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular diseaseA P Niarchos, H H Whitman, J E Goldstein, et al.
Federation Proceedings|June 1, 1982
The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertensionJ H Laragh, J E Sealey, A P Niarchos, et al.
Clinical Pharmacology and Therapeutics|November 1, 1980
Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertensionA P Niarchos, T G Pickering, J M Wallace, et al.
The American Journal of Cardiology|September 1, 1984
Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertensionJ Fisher, J S Borer, J W Moses, et al.
Pageof 3